메뉴 건너뛰기
Archives of Ophthalmology
Volumn 125, Issue 4, 2007, Pages 557-558
Bevacizumab vs ranibizumab treatment for age-related macular degeneration: A head-to-head comparison is needed
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;
EID: 34247133813     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.4.557     Document Type: Note
Times cited : (3)
References (3)
  • 1
    • 33749445317 scopus 로고    scopus 로고
    • MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration
    • Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419-1431.
    • (2006) N Engl J Med , vol.355 , pp. 1419-1431
    • Rosenfeld, P.J.1    Brown, D.M.2    Heier, J.S.3
  • 2
    • 33749451356 scopus 로고    scopus 로고
    • ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration
    • Brown DM, Kaiser PK, Michels M, et al; ANCHOR Study Group. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432-1444.
    • (2006) N Engl J Med , vol.355 , pp. 1432-1444
    • Brown, D.M.1    Kaiser, P.K.2    Michels, M.3
  • 3
    • 33749440219 scopus 로고    scopus 로고
    • Age-related macular degeneration
    • de Jong PT. Age-related macular degeneration. N Engl J Med. 2006;355:1474-1485.
    • (2006) N Engl J Med , vol.355 , pp. 1474-1485
    • de Jong, P.T.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.